Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Predictive modeling techniques in prostate cancer.

A Tewari1, C Porter, J Peabody

  • 1Vattikuti Urology Institute and Josephine Ford Cancer Center, Henry Ford Hospital, Detroit, Michigan, USA.

Molecular Urology
|January 16, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Kinetics and thermodynamics of BI-BII interconversion altered by T:G mismatches in DNA.

Biophysical journal·2022
Same author

Early mortality risk stratification after SARS-CoV-2 infection.

Medicina intensiva·2021
Same author

Anti-Ku-positive juvenile dermatomyositis.

Clinical and experimental dermatology·2021
Same author

Relapsing-remitting linear ecchymosis.

Clinical and experimental dermatology·2021
Same author

Early mortality risk stratification after SARS-CoV-2 infection.

Medicina intensiva·2020
Same author

Type I and type IV systemic contact dermatitis to balsam of Peru with a particular reaction to cinnamyl alcohol.

Clinical and experimental dermatology·2020
Same journal

Status and prospects of gene therapy for urologic cancer. First Meeting of the Japanese Society for Urological Gene Therapy. November 20, 1999. Okayama, Japan.

Molecular urology·2002
Same journal

Application of conditionally replicating herpes vector for gene therapy treatment of urologic neoplasms.

Molecular urology·2002
Same journal

Tissue-specific promoters in gene therapy for the treatment of prostate cancer.

Molecular urology·2002
Same journal

Suicide gene therapy for urogenital cancer: current outcome and prospects.

Molecular urology·2002
Same journal

Hammerhead ribozymes as therapeutic agents for bladder cancer.

Molecular urology·2002
Same journal

Application of antisense technology to urologic cancers.

Molecular urology·2002
See all related articles

New predictive modeling techniques offer advanced tools for prostate cancer management. These methods, used alone or with traditional approaches, aid clinicians and patients in making informed decisions.

Area of Science:

  • Oncology
  • Biostatistics
  • Medical Informatics

Background:

  • Prostate cancer management relies on accurate prognostication and treatment selection.
  • Traditional modeling techniques have limitations in predicting patient outcomes.
  • Emerging computational and statistical methods offer new avenues for predictive accuracy.

Purpose of the Study:

  • To review novel predictive modeling techniques applicable to prostate cancer.
  • To highlight the potential of these methods for improving patient management.
  • To inform researchers and clinicians about advanced predictive tools.

Main Methods:

  • Literature review of recent advancements in predictive modeling.
  • Focus on techniques applicable to clinical and translational research in prostate cancer.

Related Experiment Videos

  • Discussion of methods that can be integrated with existing management strategies.

    • Main Results:

    • Several new predictive modeling techniques have been identified.
    • These methods demonstrate potential for enhancing the accuracy of prostate cancer prognostication.
    • Integration of these techniques can lead to more personalized treatment strategies.

    Conclusions:

    • New predictive modeling techniques represent a significant advancement in prostate cancer research.
    • These tools can empower clinicians and patients with more precise information for management decisions.
    • Further investigation and implementation of these methods are warranted for optimal prostate cancer care.